Analyst Ratings for CVS Health (CVS)
CVS Rating Summary
CVS Price Target Summary
- Highest: $113.00 (Piper Sandler)
- Lowest: $80.00 (Jefferies)
- Average: $100.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$100.10 (+9.6%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 88%
Avg. $ Target:
$100.10 (+9.6%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Nephron | Eric Percher | New Coverage | Hold (N/A) |
84.00 (N/A) |
77.30 (91.37) |
18.2% | Details |
| 3/12/2026 | Bernstein SocGen Group » Updated 5/12/2026 |
Lance Wilkes | Upgrade | Outperform (Market Perform) |
106.00 (94.00) |
75.72 (91.37) |
20.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
